🔗 Share this article

A shadow market for unlicensed slimming medications is being driven by social media fitness personalities and vendors on messaging platforms, according to recent findings.

Investigational Treatment Acquiring Traction Online

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its supposed weight-reducing properties. Followers are encouraged to contact these accounts privately for source information, while also receiving discount codes.

Thriving Trade on Messaging Platforms

Separately, a robust market exists on Telegram, where groups with numerous of participants share comparison photos, administration instructions and claims of next-day UK delivery. Sellers promote the substance there before directing customers to WhatsApp for purchases.

Learning About Retatrutide

Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Experts Express Worries

However, physicians and pharmacists have cautions that the distribution of what remains an unapproved drug in the United Kingdom is a cause for concern and could result in individuals injecting products of unknown origin.

Several professionals said the popularity for retatrutide could be linked to the increasing cost of approved slimming treatments such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Several content creators try to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still breach pharmaceutical, marketing, and consumer laws, risking fines, prosecution or imprisonment.

Platform Response and Material Elimination

Based on TikTok, the service has taken down violative content and banned related keywords and search suggestions. The organization stated it was committed to maintaining the service safe and allocating resources in enhancing compliance measures.

Online Trading Operations

Investigations also found groups with up to 9,000 members selling retatrutide using the platform's integrated search feature, which operates like a public directory. Typing “retatrutide” instantly brings up groups with thousands of users, filled with images of slimming results, glowing testimonials and step-by-step guides for mixing or administering at home.

After minutes of joining one group, a vendor shared contact information, where the majority of transactions occur. The seller sent an guidebook and promised delivery within two days. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one asked about weight, health issues or past usage.

Product Information and Pricing

Within these groups, messages show dark colored parcels with postal service stickers, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at residence with sterile water, or pre-filled injectors usually priced at 160 pounds for 20mg. When questioned how much time a injector should be used, vendors give contradictory answers ranging from a few weeks to “depends on your body”.

Platform Oversight and Security Measures

A spokesperson for the messaging service stated it actively monitored harmful material on its platform including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are administering substances they cannot confirm. Although the science behind retatrutide is valid, these online versions may not include what they claim,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the increase in interest to recent cost increases for approved weight-loss medications such as Mounjaro. “With prices rising, patients are using online platforms. But fake treatments are highly risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she explained.

Her team has previously seen individuals injured by personal administration from unconfirmed sources. “We understand the frustration, but purchasing from Telegram or WhatsApp is taking chances with your health,” stated Wyllie. “These substances could be impure or incorrectly dosed.”

Producer Statement

A representative from Eli Lilly stated retatrutide was in third stage clinical trials and had not been evaluated or authorized by any government authority globally. “Therefore at this point no one can market [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a company experimental product not yet authorized … may expose users to possibly serious medical dangers”.